The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 10, 2014

Filed:

May. 04, 2010
Applicants:

Claire Abadie, Annecy, FR;

Jean-marc Combette, Saint-Cergues, FR;

Catherine Deloche, Geneva, CH;

Robert Anthony Williamson, La Jolla, CA (US);

Inventors:

Claire Abadie, Annecy, FR;

Jean-Marc Combette, Saint-Cergues, FR;

Catherine Deloche, Geneva, CH;

Robert Anthony Williamson, La Jolla, CA (US);

Assignee:

Ribovax Biotechnologies S.A., Petit-Lancy, CH;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/00 (2006.01); C07K 16/08 (2006.01); A61K 9/00 (2006.01); A61K 39/00 (2006.01); A61K 39/245 (2006.01);
U.S. Cl.
CPC ...
A61K 39/00 (2013.01); A61K 2039/505 (2013.01); A61K 2201/01 (2013.01); C07K 16/085 (2013.01); C07K 16/087 (2013.01); C07K 16/08 (2013.01); C07K 16/00 (2013.01); A61K 2039/55511 (2013.01); A61K 2121/00 (2013.01);
Abstract

The present invention relates to the use of a fully human antigen binding fragment of an antibody for the manufacture of a medicament for the treatment or diagnosis of an ocular disease upon topical administration. The invention further relates to a pharmaceutical composition comprising a fully human binding fragment of an antibody for ocular topical administration for treatment or diagnosis of an ocular disease. In particular, the antibody neutralizes HSV1 and HSV2.


Find Patent Forward Citations

Loading…